i
Information for healthcare providers on obtaining and using TPOXX (Tecovirimat) for treatment of monkeypox
-
September 2, 2022
Details:
-
Corporate Authors:
-
Description:Updated September 2, 2022
CDC, in partnership with FDA, has made it easier for healthcare providers to provide tecovirimat (TPOXX) treatment to patients with monkeypox under EA-IND. The streamlined process reduces the number of required forms and gives patients the option to see their doctor virtually.
-
Content Notes:How to obtain TPOXX -- Protocol -- Required -- Optional -- Institutional Review Board (IRB) Approval
-
Subjects:
-
Document Type:
-
Name as Subject:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: